Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

475
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
475
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

9.9K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

3.6K
3.6K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

18.6K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.6K
piRNA - Piwi-interacting RNAs02:57

piRNA - Piwi-interacting RNAs

7.6K
PIWI-interacting RNAs, or piRNAs, are the most abundant short non-coding RNAs. More than 20,000 genes have been found in humans that code for piRNAs while only 2000 genes have been found for miRNAs. piRNAs can act at the transcriptional and post-transcriptional levels and have a vital role in silencing transposable elements present in germ cells. They are also involved in epigenetic silencing and activation. Previously, they were thought to function only in germ cells but new evidence suggests...
7.6K
Small interfering RNAs (siRNA)02:30

Small interfering RNAs (siRNA)

4.4K
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Epigenetic Regulator Histone Demethylase KDM5A is Activated and Pathogenic in a Mouse Model of Heart Failure.

bioRxiv : the preprint server for biology·2026
Same author

Cardiomyocyte cytosolic nuclear self-DNA contributes to the pathogenesis of desmoplakin cardiomyopathy.

JCI insight·2025
Same author

The CGAS-STING1 Pathway as a Mediator of Innate Immune Response in Cardiovascular Disease.

JACC. Asia·2025
Same author

Epigenetic regulation of heart failure.

Current opinion in cardiology·2024
Same author

DNA double-stranded breaks, a hallmark of aging, defined at the nucleotide resolution, are increased and associated with transcription in the cardiac myocytes in LMNA-cardiomyopathy.

Cardiovascular research·2024
Same author

Fueling cardiac myocyte proliferation.

The journal of cardiovascular aging·2024

Related Experiment Video

Updated: Jan 28, 2026

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

9.3K

Noncoding RNAs in cardiovascular diseases.

Priyatansh Gurha1

  • 1Center for Cardiovascular Genetics, Institute of Molecular Medicine, The University of Texas Health Sciences Center at Houston, Texas, USA.

Current Opinion in Cardiology
|February 22, 2019
PubMed
Summary
This summary is machine-generated.

Long noncoding RNAs (lncRNAs) play crucial roles in cardiovascular diseases, influencing cardiac function and regeneration. Understanding lncRNA mechanisms is key to developing novel RNA therapeutics for heart conditions.

More Related Videos

Isolation of Small Noncoding RNAs from Human Serum
06:44

Isolation of Small Noncoding RNAs from Human Serum

Published on: June 19, 2014

18.6K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Related Experiment Videos

Last Updated: Jan 28, 2026

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR
13:04

Overexpressing Long Noncoding RNAs Using Gene-activating CRISPR

Published on: March 1, 2019

9.3K
Isolation of Small Noncoding RNAs from Human Serum
06:44

Isolation of Small Noncoding RNAs from Human Serum

Published on: June 19, 2014

18.6K
In Silico Clinical Trials for Cardiovascular Disease
09:09

In Silico Clinical Trials for Cardiovascular Disease

Published on: May 27, 2022

2.2K

Area of Science:

  • Molecular Biology
  • Genetics
  • Cardiovascular Research

Background:

  • The human genome is extensively transcribed, generating various coding and noncoding RNAs.
  • Long noncoding RNAs (lncRNAs) are increasingly recognized for their significant roles in cardiovascular pathophysiology.

Purpose of the Study:

  • To summarize recent findings on the functional roles of lncRNAs in cardiovascular diseases.
  • To highlight the potential of lncRNAs as therapeutic targets for heart conditions.

Main Methods:

  • Literature review of recent studies on lncRNA function in cardiovascular contexts.
  • Analysis of lncRNA mechanisms, including competing RNA interactions and protein targeting guidance.

Main Results:

  • lncRNAs are implicated in cardiac regeneration, conduction, hypertrophy, and endothelial function.
  • Mechanisms include sequestering microRNAs and guiding protein targeting; some lncRNAs encode peptides regulating cardiac calcium homeostasis.

Conclusions:

  • Noncoding RNAs, particularly lncRNAs, offer versatile gene regulation and represent novel therapeutic targets for cardiovascular diseases.
  • Further research into context-dependent lncRNA mechanisms is essential for advancing RNA therapeutics.